A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

Search Engine Marketing Archive

Is Facebook Where It’s At For Rare Diseases?

Posted by | 4:28pm on Thursday, February 25, 2016 | 1 Comment
Facebook and Rare Diseases by the numbers

Rare diseases by the numbers:  

  • 7,000 different types of rare diseases
  • 30 million people in the US living with rare diseases or 10% of the US population
  • 50% affected by rare disease are children

Facebook usage by the numbers:

  • 161 million daily active users in the US
  • Users spend 40 minutes (on Facebook) in the US per day alone

So what does all this mean?

Imagine having 500 friends on Facebook and up to 100 of them has a rare disease or is the caregiver of someone with one.

Rare doesn’t seem so rare any more.

It probably isn’t a huge leap to suggest (as implied above) that a high percentage of those affected by a rare disease are on Facebook, so what does that mean for a drug manufacturer or an advocacy group?

Fish where the fish are

If you are trying to build an advocacy or support group, you want to make it as easy as possible for people to join, participate, engage, and find the support desired.  If you are trying to promote or build awareness for a rare disease therapy, you want to be where people are discussing the disease and spending a significant amount of time.  Facebook has organically become such a place.

On average, Facebook users (in the US) spend 40 minutes per day on Facebook.  People affected by rare diseases (both directly and indirectly) are usually very knowledgeable and strong advocates who are looking for community.  No one with a rare disease wants to feel like they are alone.

This makes Facebook a perfect place to facilitate this community (and build awareness for a group, therapy or drug at the same time).  To borrow a phrase from a friend, Ted Rubin, Facebook is an ideal social media channel to maximize a brand or organization’s Return on Relationship™ or ROR.

What is Return on Relationship™?     

According to Ted’s blog, ROR in this case is the value accrued by a brand (or association) due to nurturing a relationship.  ROR can and should lead to a Return on Investment (ROI) but it’s much more than just a monetary metric.  Yes, there is a financial incentive for brands (for example) to encourage adherence.  But in the end, all of us in the rare disease space are trying to help others find relief through treatment that can improve quality of life, empower with information to take control, and enable a community so no one feels like they have to “do it alone”.

Having a rare disease can be very challenging and downright frustrating on a number of levels.  The entire process of being diagnosed with a rare disease can take years.  Once diagnosed, regaining control of your life and learning about treatment options can take more time.  And finally once treatment is started, determining the correct dosage and staying on drug can be a process.

Engagement and building relationships with patients and caregivers (in other words developing a strong ROR) is what ties this all together and ultimately leads to ROI in the long run.

Stay tuned in the coming months as we explore all the tools Facebook offers to maximize ROR and in turn ROI from both a content and advertising perspective.  

Facebook Stickers

More Robust Facebook Behavioral Targeting

There’s a lot more going on these days on Facebook than the ability to dislike a status update.  Facebook recently…

Tags: , , , , , , , ,

Facebook Changes CPC Calculation

Facebook Updates CPC Calculation

Facebook is making changes to how the Cost Per Click is calculated for their advertising.   At its most basic level,…

Tags: , , , , ,

Google logo

Google Shakes up Adwords – No More Special Treatment for Pharma Ads

Google is making some big-ish changes to Adwords specifically affecting the pharmaceutical industry.  The first change will undo the process…

Tags: , , , , ,


FindZebra: Rare Disease Search Engine

Physicians are trained to arrive at a medical diagnosis by starting with the potential causes that are most common. The…


FDA Letter Mentions Internal Site Search

We recently reviewed this FDA warning letter sent on January 29, 2013 to Medical Doctors Research (MDR), a nutritional supplement…


example of Facebook Graph Search

Facebook Graph Search – Not As Scary As It Seems

There has been a lot of buzz regarding the upcoming Facebook Graph Search launch and its effect on healthcare marketing. Some…


Physician Insights from Google’s ThinkHealth

The other day I attended the annual Google ThinkHealth event to review some of the latest digital trends. Among the…


InnovationPharm: What’s New in Search & YouTube

To keep up with what’s new and innovative in technology, as well as the biopharmaceutical industry, we have a learning…


New Data on Physicians, Search & YouTube

The Manhattan Research-Google Physician Channel Adoption Study 2012 reinforces what we already know–that physicians use general search engines for clinical…


Symptom Search with Dr. Google

In February Google announced a new enhancement to their search results for health symptoms. We have known for a long…


Three Google Innovations and Changes Pharma Needs to Know About

Google has been an important part of the health research process for patients and healthcare providers for many years. This…



Google Search Reigns Supreme Even for Doctors

Two studies were recently released regarding the online search habits of physicians. The first, Kantar Media’s Sources & Interactions, found…


Google Analytics Makes Changes in SEO Keyword Reporting

This week Google announced that it is making a change to how Google Analytics (GA) reports keyword level data. Google…


Google lollipops

What Pharma Marketers Need to Know About Google Instant

On September 8, Google Instant was launched, showing search results as the user types the query. You don’t have to…


What Do Patients Do Right After Diagnosis?

New research shows that patients turn to search engines for health and medication information, and no longer just rely on…



What’s Metadata & Why Pharma Should Care

Metadata, which is invisible to anyone viewing a website in a browser, is part of the underlying page code. Search…

Tags: ,

Google Starts Editing Drug Results

When you search a popular drug on Google the first result is now from the National Institutes of Health (NIH)….


google icon

Google 2nd to Doctors as Source of Health Info

Dr. Google is still diagnosing Americans. A recent survey found 22% consider Google searches “influential” in seeking health info. While…

Tags: ,

Social Media and Search

Soyoon Bolton, Content Strategist at Siren Interactive, contributes this post: Recently, I posted an update on my Facebook profile asking…



Is Paid Search Over For Pharma Marketers?

Lindsay Millsap, Search Engine Marketing Strategist at Siren Interactive, contributes this post: Last week, the U.S. Food and Drug Administration…


Why Search Matters More for Rare Disorders

Pamela Todd, Content Strategist at Siren Interactive, contributes this post: Search matters — especially when it comes to healthcare.  The…


Washing face

J&J Going For Niche Markets

In an October 6th Advertising Age article titled “Small Brands Could Be J&J’s Next Big Thing,” the journalist reported that…


Play by the Rules, SEO in Wikipedia

Wikipedia is fast becoming one of the top reference resources for many who are searching for information on a particular…


US Search Engine Marketing Spending, by Type, 2006-2011 (% of total and millions)

Contextual Search Ads

One of the other presenters at the CBI conference I spoke at last week really sparked my interest. Revolutionhealth was…


SEM: Technical Matchmaking

SEM through optimization and paid search campaigns for chronic and niche disease states turns out be be a great way…


Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com